CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer
ACS Applied Materials & Interfaces · 2025
DOI: 10.1021/acsami.4c21740 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Kaiyong Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China. Hauptthemen laut MEDLINE: Tyrosine Kinase Inhibitors, PTEN Phosphohydrolase, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Graduate Research and Innovation Projects of Jiangsu Province, Major Project of Philosophy and Social Science Research in Colleges and Universities of Jiangsu Province, Harbin Medical University Cancer Hospital.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
- Department of Emergency Medicine, Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210002, China.
- Department of Breast Surgery, Harbin Medical University Cancer Hospital, 150 Haping Road, Harbin 150081, China.
ORCID-Profile: Xin Han
Förderung
- Graduate Research and Innovation Projects of Jiangsu Province
- Major Project of Philosophy and Social Science Research in Colleges and Universities of Jiangsu Province
- Harbin Medical University Cancer Hospital
- National Natural Science Foundation of China
- Jiangsu Key Discipline Construction Fund of the 14th Five-Year Plan
- National Natural Science Foundation supporting project of Nanjing University of Chinese Medicine
- Yangtze River Delta joint sci-tech innovation and research projects
Zitieren
APA
Yang, K., Zhang, C., Wang, Z., Huang, Q., Qian, J., Shi, G., Sun, W., Wang, J., Ji, Y., Sun, Z., Song, Y., & Han, X. (2025). CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c21740
Vancouver
Yang K, Zhang C, Wang Z, Huang Q, Qian J, Shi G, et al. CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c21740
BibTeX
@article{Yang2025,
author = {Yang, Kaiyong and Zhang, Chunli and Wang, Zeyu and Huang, Qiqing and Qian, Jing and Shi, Gaoyu and Sun, Wenwen and Wang, Jinqiu and Ji, Yu and Sun, Zhaorui and Song, Yanni and Han, Xin},
title = {CRISPR-dCas9-Mediated PTEN Activation via Tumor Cell Membrane-Coated Nanoplatform Enhances Sensitivity to Tyrosine Kinase Inhibitors in Nonsmall Cell Lung Cancer},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
doi = {10.1021/acsami.4c21740}
}
EUVIMED